(Press-News.org) More than half of the experts on the UK government’s nutrition advisory panel have links to the food industry, reveals an investigation by The BMJ today.
At least 11 of the 17 members of the Scientific Advisory Committee on Nutrition (SACN) have conflicts of interest with the likes of Nestle, sugar manufacturer Tate and Lyle, and the world’s largest ice cream producer, Unilever, reports freelance journalist Sophie Borland.
And at least six out of the 11 members of SACN’s Subgroup on Maternal and Child Nutrition have ties to food firms, including baby food manufacturers and formula milk brands.
SACN is a powerful group of people appointed as independent experts to advise the government, which in turn influences policy, explains Borland. Since being set up in 2000 it has produced high profile guidelines on daily salt and sugar intake, vitamin D supplements, and feeding babies.
But there is concern that both SACN – and the previous governments reviewing its recommendations – have not done enough to curb rising obesity levels and food-related ill health.
The BMJ looked at the interests declared by SACN members – in publicly available documents published on the government website – within the past three years.
Among them is David Mela, a retired senior scientist from Unilever, who has done consultancy work for Unilever, Tate and Lyle, Coca Cola’s Israel franchise CBC Israel, and Cargill, which produces cocoa and chocolate products among other things.
Another member, Julie Lovegrove, is chair of an expert group at the International Life Sciences Institute (ILSI) Europe, whose member companies include Pepsico, Cadbury’s US owner Mondelez, and General Mills, the American firm behind Cheerios and Haagen Dazs.
Members of SACN’s Maternal and Child Nutrition subgroup include Ann Prentice, a council member of the Nestle Foundation, and Marion Hetherington who has undertaken work for Danone and baby food brand Ella’s Kitchen, the latter on an unpaid basis. The group’s chair, Ken Ong, has also received research funding from Mead Johnston Nutrition, which makes formula milk.
The Department for Health and Social Care (DHSC) responded on behalf of SACN and all members named in this article, saying SACN members are required to declare any potential conflicts of interest annually – and new ones at the first appropriate committee meeting, which are included in the minutes and published on the SACN website.
It added: “No members of the committee are directly employed by the food and drink industry, and all have a duty to act in the public interest and to be independent and impartial.”
But Chris van Tulleken, associate professor at University College London and author of a best-selling book on ultra-processed food, says: “Even small financial conflicts affect behaviour and beliefs in subtle or unconscious ways,” while Rob Percival, head of policy at the Soil Association, says: “We’re concerned that the committee and its integrity might be undermined by those ties to the food industry.”
Experts tell The BMJ the make-up of SACN needs to be reviewed in light of members’ ties to the food industry. However, Kat Jenner, director of the Obesity Health Alliance, says these ties are partly a result of the lack of money in relevant research.
Alison Tedstone, former chief nutritionist for Public Health England, also suggests that refusing to allow experts with industry ties on SACN would “diminish” its expertise and could delay future legislation.
Yet Van Tulleken insists: “Despite two decades of work from a conflicted SACN there has been an explosion of suffering and death from diet-related disease in the UK so I don’t think it’s credible to claim that the committee has been very effective.
“There are some excellent independent experts but they are a minority and in my view their work has been hampered by conflicts of interest with the industry that has created this health crisis. SACN must become independent of the food industry.”
[Ends]
END
More than half of UK government nutrition advisors are paid by food companies
11 of 17 advisors have links with firms including Nestle, Tate and Lyle, and Unilever. Campaigners say conflicts are detrimental to public health; others say ties are partly a result of a lack of money in relevant research
2024-09-11
ELSE PRESS RELEASES FROM THIS DATE:
Shorter-course radiation better option for breast cancer patients than conventional schedule
2024-09-11
Giving higher doses per fraction of radiation therapy over a shorter time after breast cancer surgery significantly reduces the risk of side effects and improves quality of life compared with a conventional schedule, finds a study published by The BMJ today.
Although survival and recurrence rates were similar, this approach, known as hypofractionation, is safer, more convenient for patients, and reduces costs for healthcare systems, and should be the preferred treatment option, say the researchers.
Conventional fractionation radiation therapy has been the standard of care for most patients with breast ...
Obesity treatments being restricted by cash poor local services
2024-09-11
Obesity treatments are being restricted by cash poor local services across England with many patients being denied specialist drugs, surgery and support, an investigation by The BMJ has found.
Patients in nearly half the country can’t get appointments with specialist teams for weight loss support and care, including treatment with drugs such as semaglutide. And in nearly one in five local health areas, patients don’t have access to a bariatric surgery service, reports Elisabeth Mahase.
The government estimates that obesity costs the NHS in England around £6.5bn a year and is the second biggest preventable cause ...
Laughter may be as effective as drops for dry eyes
2024-09-11
Laughter may be as effective as eye drops in improving symptoms of dry eye disease, finds a clinical trial from China published by The BMJ today
The researchers suggest that laughter exercise could be an initial treatment for relieving symptoms of dry eye disease.
Dry eye disease (DED) is a chronic condition estimated to affect around 360 million individuals worldwide. Common symptoms include uncomfortable, red, scratchy or irritated eyes.
Evidence suggests that laughter therapy alleviates depression, anxiety, stress, and chronic pain, while strengthening immune ...
Path to prosperity for planet and people if Earth’s critical resources are better shared: report
2024-09-11
Earth will only remain able to provide even a basic standard of living for everyone in the future if economic systems and technologies are dramatically transformed and critical resources are more fairly used, managed and shared, according to an international research team including scientists from The Australian National University (ANU).
The report, published in The Lancet Planetary Health, outlines how cities and businesses have the power to play a crucial role and become the “stewards” of critical Earth ...
Long-course radiotherapy is better than short-course for organ preservation in rectal cancer
2024-09-11
The COVID-19 pandemic has enabled researchers to show that a long course of radiotherapy given before surgery may be a better treatment for avoiding surgery, preserving the rectum and anus, and preventing regrowth of the primary tumour than a short course of radiotherapy for patients with rectal cancer – a type of bowel cancer. However, the overall survival and survival free of recurrence of the disease remained the same for both treatments.
These findings are from a new study published in ...
Large-scale population analysis confirms reassuring safety profile of tirzepatide
2024-09-11
As more people with type 2 diabetes (T2D) are taking medications to help manage blood sugar levels and weight loss, concerns about whether these drugs are safe have emerged. Now real-world evidence from the FDA Adverse Event Reporting System (FAERS) database reveals a reassuring safety profile for tirzepatide (TZP).
The findings to be presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept), and published in the The Journal of Endocrinological Investigation (link below) reveal that, compared to the widely used class of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), TZP has similar gastrointestinal ...
Tirzepatide associated with greater weight loss in women than men
2024-09-11
All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but women experienced greater weight loss, according to new post hoc research to be presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).
The post hoc analysis, which included the four SURMOUNT trials [1], compared tirzepatide with a placebo for up to 72 to 88 weeks in 4,677 adults (2,999 females, 1,678 males) living with obesity, highlighting potential sex differences in the response.
Tirzepatide, a once-weekly glucose-dependent ...
Rapid control of blood sugar levels in women with gestational diabetes can reverse the risk of their children developing obesity, US study finds
2024-09-11
Swiftly achieving glycaemic control after a diagnosis of gestational diabetes can bring the baby’s risk obesity in childhood down to a level similar to that of children whose mothers did not have gestational diabetes, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September), has found.
Gestational diabetes, a type of diabetes that can develop during pregnancy, affects 14% of pregnant women globally and is becoming more common, with those who are living with obesity, have a family ...
Semaglutide’s cardiovascular benefits are maintained in people with impaired kidney function
2024-09-11
The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with overweight or obesity who don’t have diabetes, whether or not they also have impaired kidney function, according to new research to be presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).
The results are based on a pre-specified analysis of the SELECT trial which found that adults with overweight or obesity but not diabetes taking semaglutide for more than 3 years had a 20% lower risk of MACE or ...
Study reveals key predictors for achieving and sustaining blood glucose control and weight loss with tirzepatide in adults with type 2 diabetes
2024-09-11
The phase 3 SURPASS-4 trial published in 2021 established that tirzepatide lowers blood sugar and supports weight loss better than insulin glargine (a long-acting insulin) for type 2 diabetes (T2D) [1]. Now new research examining a broad range of potential predictors of sustaining blood sugar control and weight loss indicates that greater weight loss, better β-cell function, and a greater decrease in low-density lipoprotein cholesterol (LDL-C or “bad cholesterol”) during the first year of tirzepatide therapy are the most ...
LAST 30 PRESS RELEASES:
Arthropods dominate plant litter decomposition in drylands
World-renowned organic chemists attend inaugural science symposium hosted by Rice’s Global Paris Center
The trees of Miami’s future
MIT team takes a major step toward fully 3D-printed active electronics
Accelerated three-year medical school students perform as well as peers in traditional four-year programs
SwRI-developed instruments will study potential habitability of Jupiter’s moon Europa
Proposed scoring system may enhance equity in organ transplantation, increase transplant rates and improve patient survival
Survivors of childhood brain cancer are more likely to be held back in school
Updating offshore turbine designs to reflect storms’ complexity is key
Hospital strain during the COVID-19 pandemic and outcomes in older racial and ethnic minority adults
Scientists unveils key role of “selfish DNA” in early human development
Bonobos may be more vulnerable than previously thought, suggests genetics study
Scripps Research scientists discover chemical probes for previously “undruggable” cancer target
Giant Magellan telescope begins primary mirror support system testing
Experimental cancer drug eliminates bone metastases caused by breast cancer in lab models
Political candidates who fight climate change stand to benefit in election
Stand up to Cancer announces new grants supporting pioneering research in six cancer types
Researchers awarded $1.3M to help military Veterans battling Acute Myeloid Leukemia
New hub for high-energy astrophysics — CTAO Science Data Management Centre opens at DESY in Zeuthen
JMIR publications CEO and Executive Editor Gunther Eysenbach achieves #1 ranking as most cited researcher in Medical Informatics for fifth consecutive year
ERC grant for groundbreaking wearable health tech
NIH announces winners of prize competition to improve postpartum maternal health and health equity through innovative diagnostics
APS and SPR honor Dr. Cynthia F. Bearer with the 2025 Mary Ellen Avery Neonatal Research Award
Election delays and voter trust
US air pollution monitoring network has gaps in coverage, say researchers
Continuous monitoring of fatigue in factory workers
Farmer ants’ wearable bacteria
Political polarization and trust
Study uncovers how silkworm moth's odor detection may improve robotics
New study links obesity to elevated hypertension risk among young middle eastern women
[Press-News.org] More than half of UK government nutrition advisors are paid by food companies11 of 17 advisors have links with firms including Nestle, Tate and Lyle, and Unilever. Campaigners say conflicts are detrimental to public health; others say ties are partly a result of a lack of money in relevant research